Operational & Sector-Specific

Facing a massive skilled trades shortage, Alberta's industry has a choice: tap into a growing Indigenous workforce or let bias cripple its future.

Pluristyx secures a key Japanese patent for its rapid mRNA reprogramming tech, slashing iPSC production time and promising to unlock commercial-scale cell therapy.

A new surgical method called SMART, developed at Delray Medical Center, uses biological scaffolds to overcome the failure of sutures in critical muscle injuries.

Biotech firm ProJenX reports its novel ALS drug, prosetin, is safe and hits key targets in early trials, offering a new beacon of hope for the disease.

A single soldier controlling a swarm of drones in a contested battle. Palladyne AI's recent test with the U.S. Army signals a major leap in autonomy.

V2 Cloud’s latest move isn’t just a tech upgrade; it’s a blueprint for how organizations can build a more equitable and productive digital workplace.

J.D. Sitton's move to National signals a broader industry trend: the critical role of veteran IR leaders in navigating a complex real estate market.

Bigleaf and CSG are rewriting the rules of business internet, combining 5G and Starlink not for backup, but for a unified, high-performance connection.

A new silicon battery from Coreshell promises a 30% performance boost and a domestic supply chain, aiming to secure U.S. military technology from foreign risk.

A new partnership between Peak Nano and Advanced Conversion solves a key thermal challenge in high-voltage EVs, strengthening the US supply chain.

After shedding its past, BitVentures reports a stunning profit. But a deep dive reveals a one-time gain and a risky bet on e-commerce and crypto mining.

Edgewise Therapeutics unveils strong Phase 2 data for its HCM drug, EDG-7500, showing efficacy without the cardiac risks plaguing market leaders.

Soma Gold isn't just hiring; it's assembling a specialized team to execute an ambitious expansion, deepen its ESG commitment, and win the mining talent war.

Eastnets' new FCIP is more than a product launch; it's a strategic move against industry fragmentation, betting on explainable AI to unify risk.

Preliminary data from a randomized trial suggests a personalized medicine approach can reverse cognitive decline, offering a glimmer of hope beyond slowing the disease.

US innovator FlexPatio enters Australia's $48B reno market with a high-tech pergola. Is its DIY-friendly, storm-proof design the key to unlocking value?

A UK firm just put its radical compute engine on AWS, promising 500x speedups and 1000x less energy for finance and AI without major code rewrites.

A legacy sports giant just rewrote the playbook on tech adoption, deploying a new contact center in hours, not months. Here's what it signals about value and resilience.

International Petroleum Corp. celebrates a major win with its Blackrod project, delivering oil ahead of schedule. But the real story is in the data.

Marwest REIT's modest 2.1% distribution increase reveals deep financial stability in Western Canada's rental market, a stark contrast to national trends.